These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37960157)

  • 1. Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lacasa M; Alegre-Martin J; Sentañes RS; Varela-Sende L; Jurek J; Castro-Marrero J
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
    Castro-Marrero J; Segundo MJ; Lacasa M; Martinez-Martinez A; Sentañes RS; Alegre-Martin J
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Castro-Marrero J; Zaragozá MC; López-Vílchez I; Galmés JL; Cordobilla B; Maurel S; Domingo JC; Alegre-Martín J
    Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34201806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
    Cash A; Kaufman DL
    J Transl Med; 2022 Jun; 20(1):295. PubMed ID: 35764955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
    Castro-Marrero J; Domingo JC; Cordobilla B; Ferrer R; Giralt M; Sanmartín-Sentañes R; Alegre-Martín J
    Antioxid Redox Signal; 2022 Apr; 36(10-12):729-739. PubMed ID: 35229657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myalgic Encephalomyelitis-Chronic Fatigue Syndrome Common Data Element item content analysis.
    Slavin MD; Bailey HM; Hickey EJ; Vasudevan A; Ledingham A; Tannenbaum L; Bateman L; Kaufman DL; Peterson DL; Ruhoy IS; Systrom DM; Felsenstein D; Kazis LE
    PLoS One; 2023; 18(9):e0291364. PubMed ID: 37698999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.
    Campagnolo N; Johnston S; Collatz A; Staines D; Marshall-Gradisnik S
    J Hum Nutr Diet; 2017 Jun; 30(3):247-259. PubMed ID: 28111818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
    Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
    J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D status in chronic fatigue syndrome/myalgic encephalomyelitis: a cohort study from the North-West of England.
    Earl KE; Sakellariou GK; Sinclair M; Fenech M; Croden F; Owens DJ; Tang J; Miller A; Lawton C; Dye L; Close GL; Fraser WD; McArdle A; Beadsworth MBJ
    BMJ Open; 2017 Nov; 7(11):e015296. PubMed ID: 29118054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of chronic fatigue syndrome/myalgic encephalomyelitis in a pediatric population: A scoping review.
    Collard SS; Murphy J
    J Child Health Care; 2020 Sep; 24(3):411-431. PubMed ID: 31379194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring Symptom Fluctuations and Triggers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Novel Patient-Centred N-of-1 Observational Designs: A Protocol for a Feasibility and Acceptability Study.
    McDonald S; Tan SX; Banu S; van Driel M; McGree JM; Mitchell G; Nikles J
    Patient; 2022 Mar; 15(2):197-206. PubMed ID: 34368926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME.
    Daniels J; Brigden A; Kacorova A
    Psychol Psychother; 2017 Sep; 90(3):502-509. PubMed ID: 28244209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
    Toogood PL; Clauw DJ; Phadke S; Hoffman D
    Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.
    Strayer DR; Carter WA; Stouch BC; Stevens SR; Bateman L; Cimoch PJ; Lapp CW; Peterson DL; ; Mitchell WM
    PLoS One; 2012; 7(3):e31334. PubMed ID: 22431963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurovascular Dysregulation and Acute Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Placebo-Controlled Trial of Pyridostigmine.
    Joseph P; Pari R; Miller S; Warren A; Stovall MC; Squires J; Chang CJ; Xiao W; Waxman AB; Systrom DM
    Chest; 2022 Nov; 162(5):1116-1126. PubMed ID: 35526605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review of Mind-Body Interventions to Treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Khanpour Ardestani S; Karkhaneh M; Stein E; Punja S; Junqueira DR; Kuzmyn T; Pearson M; Smith L; Olson K; Vohra S
    Medicina (Kaunas); 2021 Jun; 57(7):. PubMed ID: 34202826
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.
    Capdevila L; Castro-Marrero J; Alegre J; Ramos-Castro J; Escorihuela RM
    Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial.
    Baos S; Brigden A; Anderson E; Hollingworth W; Price S; Mills N; Beasant L; Gaunt D; Garfield K; Metcalfe C; Parslow R; Downing H; Kessler D; Macleod J; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Crawley E
    Trials; 2018 Feb; 19(1):136. PubMed ID: 29471861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Collatz A; Johnston SC; Staines DR; Marshall-Gradisnik SM
    Clin Ther; 2016 Jun; 38(6):1263-1271.e9. PubMed ID: 27229907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.